Glycyrrhizin regulates CD4+T cell response during liver fibrogenesis via JNK, ERK and PI3K/AKT pathway

International Immunopharmacology

Volumn 14, Issue 4, 2012, Pages 410-421

  Tu, Chuan Tao ^a   Li, Jing ^b   Wang, Fu Ping ^a   Li, Lei ^a   Wang, Ji Yao ^a   Jiang, Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

CD4+T cells; Concanavalin A; Glycyrrhizin; Liver fibrosis; MAPK ERK; PI3K AKT

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA SMOOTH MUSCLE ACTIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GAMMA INTERFERON; GLYCYRRHIZIC ACID; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; FIBROGENESIS; HEPATITIS; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CONCANAVALIN A; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; GLYCYRRHIZIC ACID; INTERFERON-GAMMA; INTERLEUKIN-10; LIVER CIRRHOSIS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 84867015860     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.08.013     Document Type: Article

References (44)

1. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J Clin Invest 117 2007 8 539
2. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 2008 1655 1669
3. A. Leask, and D.J. Abraham TGF-beta signaling and the fibrotic response FASEB J 18 2004 816 827
4. U.E. Lee, and S.L. Friedman Mechanisms of hepatic fibrogenesis Best Pract Res Clin Gastroenterol 25 2011 195 206
5. N. Hashimoto, S. Shimoda, H. Kawanaka, K. Tsuneyama, H. Uehara, and T. Akahoshi Modulation of CD4â?° T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis Clin Exp Immunol 165 2011 243 250
6. F. Heymann, L. Hammerich, D. Storch, M. Bartneck, S. Huss, and V. Rüsseler Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice Hepatology 55 2012 898 909
7. K.R. Karlmark, H.E. Wasmuth, C. Trautwein, and F. Tacke Chemokine-directed immune cell infiltration in acute and chronic liver disease Expert Rev Gastroenterol Hepatol 2 2008 233 242
8. D.R. Littman, and A.Y. Rudensky Th17 and regulatory T cells in mediating and restraining inflammation Cell 140 2010 845 858
9. P. Miossec, T. Korn, and V.K. Kuchroo Interleukin-17 and type 17 helper T cells N Engl J Med 361 2009 888 898
10. F. Winau, C. Quack, A. Darmoise, and S.H. Kaufmann Starring stellate cells in liver immunology Curr Opin Immunol 20 2008 68 74
11. O. Vinas, R. Bataller, P. Sancho-Bru, P. Gines, C. Berenguer, and C. Enrich Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation Hepatology 38 2003 919 929
12. A. Bot Immunoglobulin deficient mice generated by gene targeting as models for studying the immune response Int Rev Immunol 13 1996 327 340
13. F. Marra, S. Aleffi, S. Galastri, and A. Provenzano Mononuclear cells in liver fibrosis Semin Immunopathol 31 2009 345 358
14. + regulatory T cells correlate with chronic hepatitis B infection Immunology 123 2008 57 65
15. J.Y. Zhang, Z. Zhang, F. Lin, Z.S. Zou, R.N. Xu, and L. Jin Interleukin-17-producing CD4 (+) T cells increase with severity of liver damage in patients with chronic hepatitis B Hepatology 51 2010 81 91
16. C.T. Weaver, and R.D. Hatton Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective Nat Rev Immunol 9 2009 883 889
17. J.Y. Zhang, C.H. Song, F. Shi, Z. Zhang, J.L. Fu, and F.S. Wang Decreased ratio of Treg cells to Th17 correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment PLoS One 5 2010 e13869
18. + regulatory T cells plays an important role in HBV-related end-stage liver disease BMC Immunol 12 2011 47 55
19. A. Plotnikov, E. Zehorai, S. Procaccia, and R. Seger The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation Biochim Biophys Acta 1813 2011 1619 1633
20. X. Wang, J. Hao, D.L. Metzger, Z. Ao, L. Chen, and D. Ou B7-H4 treatment of T cells inhibits ERK, JNK, p38, and AKT activation PLoS One 7 2012 e28232
21. Y. Yamamura, H. Kotaki, N. Tanaka, T. Aikawa, Y. Sawada, and T. Iga The pharmacokinetics of glycyrrhizin and its restorative effect on hepatic function in patients with chronic hepatitis and in chronically carbon-tetrachloride- intoxicated rats Biopharm Drug Dispos 18 1997 717 725
22. Y. Arase, K. Ikeda, N. Murashima, K. Chayama, A. Tsubota, and I. Koida The long term efficacy of glycyrrhizin in chronic hepatitis C patients Cancer 79 1997 1494 1500
23. H. Sato, W. Goto, J. Yamamura, M. Kurokawa, S. Kageyama, and T. Takahara Therapeutic basis of glycyrrhizin on chronic hepatitis B Antiviral Res 30 1996 171 177
24. C. Fiore, M. Eisenhut, R. Krausse, E. Ragazzi, D. Pellati, and D. Armanini Antiviral effects of Glycyrrhiza species Phytother Res 22 2008 141 148
25. F. Stickel, and D. Schuppan Herbal medicine in the treatment of liver diseases Dig Liver Dis 39 2007 293 304
26. L.B. Seeff, K.L. Lindsay, B.R. Bacon, T.F. Kresina, and J.H. Hoofnagle Complementary and alternative medicine in chronic liver disease Hepatology 34 2001 595 603
27. M. Ikeda, S. Fujiyama, M. Tanaka, M. Sata, T. Ide, and H. Yatsuhashi Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C J Gastroenterol Hepatol 21 2006 122 128
28. J.Y. Wang, J.S. Guo, H. Li, S.L. Liu, and M.A. Zern Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats Liver 18 1998 180 185
29. Y. Zhang, P. Li, G. Li, X. Huang, Q. Meng, and W.Y. Lau The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model J Surg Res 142 2007 175 183
30. J.R. Jonsson, A.D. Clouston, Y. Ando, L.I. Kelemen, M.J. Horn, and M.D. Adamson Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis Gastroenterology 121 2001 148 155
31. Y. Fan, W. Weifeng, Y. Yuluan, K. Qing, P. Yu, and H. Yanlan Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation Virol J 14 2011 8 17
32. C. Feng, H. Wang, C. Yao, J. Zhang, and Z. Tian Diammoniumgly- cyrrhizinate, a component of traditional Chinese medicine Gan-Cao, prevents murine T-cell-mediated fulminant hepatitis in IL- 10- and IL-6-dependent manners Int Immunopharmacol 7 2007 1292 1298
33. M. Yoshikawa, Y. Matsui, H. Kawamoto, N. Umemoto, K. Oku, and M. Koizumi Effects of glycyrrhizin on immune-mediated cytotoxicity J Gastroenterol Hepatol 12 1997 243 248
34. Y. Shiki, K. Shirai, Y. Saito, S. Yoshida, Y. Mori, and M. Wakashin Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody J Gastroenterol Hepatol 7 1992 12 16
35. M.E. Shaneyfelt, A.D. Burke, J.W. Graff, M.A. Jutila, and M.E. Hardy Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay Virol J 3 2006 68
36. Y. Qu, W.H. Chen, L. Zong, M.Y. Xu, and L.G. Lu 18α-glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells Med Sci Monit 18 2012 BR24 BR32
37. L.D. Siracusa, R. McGrath, Q. Ma, J.J. Moskow, J. Manne, and P.J. Christner A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation Genome Res 6 1996 300 313
38. T.A. Wynn, A.W. Cheever, D. Jankovic, R.W. Poindexter, P. Caspar, and F.A. Lewis An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection Nature 376 1995 594 596
39. S.C. Katz, K. Ryan, N. Ahmed, G. Plitas, U.I. Chaudhry, and T.P. Kingham Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis J Immunol 187 2011 1150 1156
40. D. Heinrichs, M. Knauel, C. Offermanns, M.L. Berres, A. Nellen, and L. Leng Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74 Proc Natl Acad Sci USA 108 2011 17444 17449
41. S. Fujikura, H. Mizuhara, Y. Miyazawa, H. Fujiwara, and K. Kaneda Kinetics and localization of lymphoblasts that proliferate in the murine liver after Concanavalin A administration Biomed Res 17 1996 129 139
42. T. Okamoto, and T. Kanda Glycyrrhizin protects mice from concanavalin A-induced hepatitis without affecting cytokine expression Int J Mol Med 4 1999 149 152
43. M. Abe, F. Akbar, A. Hasebe, N. Horiike, and M. Onji Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis J Gastroenterol 38 2003 962 967
44. +T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients Lab Invest 92 2012 295 304